Sort
51,570 grants matching “autoimmune disease”
CAR T cell targeting of human islets
$1,446,086Seung K Kim · Stanford University · UC4 · FY2017 · DK
CD24 as Therapeutic Target for Multiple Sclerosis-phase II Competing Renewal
$1,444,734Xincheng Zheng · Oncoimmune, Inc. · R44 · FY2009 · NS
Transcriptome and epigenome analysis of helper T cell specification and plasticit
$1,444,100Chen Dong · University Of Tx Md Anderson Can Ctr · RC2 · FY2009 · AR
Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE)
$1,443,698Nancy J Olsen · Pennsylvania State Univ Hershey Med Ctr · U01 · FY2017 · AR
Studies of the Function of Naturally Occurring and Adaptive T Regulatory Cells
$1,443,432Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
The role of Galpha13 signaling in suppression of lymphoma
$1,441,999Jagan Muppidi · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Flow cytometry support to research in immune, skin, muscle and bone diseases
$1,440,711Massimo Gadina · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2020 · AR
Animal care: supporting research on autoimmune, inflammatory and muscle diseases
$1,440,426Massimo Gadina · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIG · FY2017 · AR
Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial
$1,440,303Nisha Acharya · University Of California, San Francisco · UG1 · FY2019 · EY
Translational Immunology research: a support for clinical immunological research
$1,440,104Massimo Gadina · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2022 · AR
Markers and Mechanisms of Vascular Disease in Diabetes
$1,440,016Medical University Of South Carolina · P01 · FY2002 · HL
Genetic and Environmental Modifiers Of Autoimmune Disease
$1,438,862Silvia Bolland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Molecular Mechanisms Of The Autoimmune Lymphoproliferative Syndrome And Other Immunoregulatory Disorders
$1,438,637Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Molecular and Clinical Studies of Primary Immunodeficiencies
$1,438,015Fabio Candotti · National Human Genome Research Institute · ZIA · FY2013 · HG
SLE Treatment with N-acetylcysteine
$1,437,594Andras Perl · Upstate Medical University · U01 · FY2024 · AR
Translation of the UVA Advanced Automated Insulin Delivery Systems to Clinical Care in Young Children: Glycemic Control, Regulatory Acceptance and Optimization of Day to Day Use
$1,437,367Marc D Breton · University Of Virginia · U01 · FY2021 · DK
Nervous System Development and Plasticity
$1,436,963Richard Douglas Fields · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
IdeNtifying reSponse defIninG mecHanisms for biological TherapieS in SevereAsthma (INSIGHTS ); assessing the role of CD4-CTLs
$1,436,586Gregory Seumois · San Diego Biomedical Research Institute · R01 · FY2025 · HL
Sex Hormone Regulation of Innate Immunity in Women &Men
$1,436,444Dartmouth College · P01 · FY2003 · AI
Role of Innate Immune System in Pathogen Induced Chronic Inflammation
$1,436,019Caroline A Genco · Boston University Medical Campus · P01 · FY2011 · AI
Immune Responses To Ocular Antigens
$1,435,953Igal Gery · National Eye Institute · ZIA · FY2010 · EY
Novel Transfusion Based Immune Modulation
$1,435,895Stanford University · P01 · FY2003 · HL
The role of Galpha13 signaling in suppression of lymphoma
$1,435,309Jagan Muppidi · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Replication of Human Endogenous Retroviruses in Modern Humans
$1,435,274David Michael Markovitz · University Of Michigan At Ann Arbor · R01 · FY2009 · CA
Sex, Sex Steroids &Neuroprotection
$1,434,838Oregon Health And Science University · P01 · FY2005 · NS